Skip to main content
Erschienen in: Maxillofacial Plastic and Reconstructive Surgery 1/2021

Open Access 01.12.2021 | Research

The effect of 4-hexylresocinol administration on SCC-9 cells: mass spectrometric identification of proteins and cDNA microarray analysis

verfasst von: Yei-Jin Kang, Seong-Gon Kim

Erschienen in: Maxillofacial Plastic and Reconstructive Surgery | Ausgabe 1/2021

Abstract

Background

In stress situations, bacteria produce dormancy-inducing factors to stop cell growth. The dormancy-inducing factors may have an inhibitory effect on tumor cell growth. Here we analyzed the differentially expressed protein profiles after 4-hexylresorcinol (4HR), one of the dormancy-inducing factors, administration using in vitro oral squamous carcinoma cells (SCC-9).

Method

The control group was SCC-9 cells culture without 4HR administration. The experimental group received 10 μg/mL of 4HR. Collected proteins from each group were loaded for 2D electrophoresis. Among the separated proteins, 20 differentially expressed proteins were selected and processed for LC-MS/MS.

Results

In proteomic analysis, the expression of keratin 1, keratin 10, and histone H2B were increased. In cDNA microarray assay, the genes related to the cellular differentiation (involucrin, keratin 13, 14) were highly expressed in the 4HR treated group (fold ratio > 2.0; Table 2). Interestingly, histone family was upregulated in the cDNA microarray assay.

Conclusion

The administration of 4HR on SCC-9 cells increased epithelial cell differentiation markers and histone.
Hinweise
Yei-Jin Kang and Seong-Gon Kim contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
4HR
4-hexylresorcinol
OSCC
Oral squamous cell carcinoma
NF-κB
Nuclear factor-kappaB
LC-MS/MS
Liquid chromatograph-tandem mass spectrometer

Background

Alkylresorcinols, natural non-isoprenoid lipids found in various plant and bacterial species, attract attention because of a variety of biological functions including non-specific antioxidants, antimutagens, and regulatory molecules of proliferation [1]. Chemical analogs of such lipids exert the anticancer effects as already have been proved in animal models for colon [2], lung [3], and pancreas tumors [4], mononuclear cell leukemia, hepatocellular neoplasms, and circulatory system tumors [5] without clear mechanism. The demonstrations of a potential anti-tumor effect of alkylresorcinols and their non-specificity to various tumors made us eager to undertake studies for elucidating 4-hexylresorcinol (4HR) action on oral squamous cell carcinoma (OSCC).
OSCC is a common malignant cancer, and the overall cure rate has not been improved for decades despite recent development of cancer therapeutics [6]. The drug resistance of OSCC is explained by heterogenous population of OSCC, and it is related to “field cancerization” theory [7]. If the drug has dual functions such as inducing apoptosis of active proliferating cancer cells and redifferentiation of cancer cells which escape from the apoptosis, the therapeutic effects will be increased in the heterogenous OSCC. Therefore, the chemical revertant which can inhibit cancer through induction of cancer differentiation must be developed for OSCC to improve the overall cure rate.
We believe that eukaryotic cells might also produce similar chemical analogs, and these chemicals might help to survive in the micro-environmental stress situation. Starving condition increases the sensitivity to cancer treatment and the survival of normal cells [8]. Therefore, it is reasonable to suggest that mechanisms of 4HR action, same analogy to the regulation of physiological state and activity in microorganisms, will be similar to cancer cells showing inhibition of cell proliferation. Since the anti-tumorigenic effect of 4HR has been suggested by the national toxicology program [9], 4HR-mediated anti-tumor mechanism has been illuminated. 4HR inhibits transglutaminase-2 activity [10] and subsequent nuclear factor-kappaB (NF-κB) signaling pathway [11]. 4HR stimulates the differentiation of oral cancer cells via E2F and Sp1-mediated pathways [12]. 4HR suppresses calcium oscillation in oral cancer cells [13].
The objective of this study was to determine differentially expressed proteins in SCC-9 cells after 4HR administration.

Methods

Cell cultures

SCC-9 cells from the American Type Culture Collection (ATCC; Manassas, VA) were grown to confluence in Ham’s F12/Dulbecco’s modified Eagle’s medium (Gibco, BRL, Gaithersburg, MD) containing 1% penicillin/streptomycin, fibroblast growth factor-2 (100 μg/ml), and 10% fetal calf serum (FCS). 4HR (Sigma, St. Louis, MO) was added to confluent cells to final concentrations at 10 μg/mL (50 μM).

Sample analysis by liquid chromatograph-tandem mass spectrometer (LC-MS/MS)

Analytical 2-D electrophoresis and in-gel proteolytic digestion were followed by Doucette and Li [14] and Gharahdaghi’s method [15], respectively. The final tryptic digested peptides were resolved with 7 μl deionized water (DW) in 0.1% formic acid. DW and HPLC-grade acetonitrile were used for the preparation of eluents. Chromatographic separations were performed using a Nano LC 1D system (Eksigent Technologies, CA, USA). Samples (6 μL) were injected directly onto a 150 um × 150 mm column (Vydac 218MS5, 1515; Grace Vydac, Hesperia, CA, USA) and eluted with a linear gradient of 1–80% acetonitrile (0.1% formic acid) in 120 min. Fused-silica 20 μm i.d. tubings were used for pre- and post-column liquid connections. The spots from each individual digest were analyzed by tandem mass spectrometry (MS/MS) using the QqTOF mass spectrometer (QSTAR XL, Applied Biosystems/MDS Sciex, Foster Citys, CA, USA). The built-in IDA method was used for automatic “Rolling Collision Energy” [16].

cDNA microarray

cDNA microarray analysis was performed by Genomic Tree Co. (Daejeon, Korea) using Agilent’s human whole genome 4 X 44 K chips (Santa Clara, CA). After12-hour treatment with or without 4HR (10 μg/mL) in SCC-9, total RNA was extracted using TRI Reagent as recommended by the manufacturer (Molecular Research Center, Inc. Cincinnati, OH).

MTT assay

The respiratory activity in the control and 4HR-treated cultures was assessed as previously described [17]: they were incubated in 6-well multiplates with yellow tetrazolium salt 3-(4, 5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (Cell proliferation kit I; Roche Molecular Biochemicals) for 4 hours at room temperature. Formazan crystals were solubilized overnight, and the product was quantified spectrophotometrically by measuring absorbance at 590 nm using a Victor Multilabel counter (Perkin-Elmer-Wallac, Freiburg, Germany).

Results

In proteomic analysis, the expression of keratin 1, keratin 10, and histone H2B were increased in 2-D gel electrophoresis and they were identified by Quadrupole-time of flight (Q-TOF) (Fig. 1 and Table 1). Interestingly, keratin 1 showed as 2 spots and they were shown conflicting expression patterns. Spot 8 and spot 14 were identified as keratin 1 (Fig. 1). According to MS analysis, spot 8 showed 8 amino acid matching, and spot 14 showed 12 amino acid matching. The molecular weight of spot 8 was smaller than spot 14. Therefore, highly expressed keratin 1 in the control might be a defective protein. Considering that SCC-9 has poorly differentiated cells, keratin expression could have a defect. In the cDNA microarray assay, the genes related to the cellular differentiation (involucrin, keratin 13, 14) were highly expressed in the 4HR treated group (fold ratio > 2.0; Table 2). Interestingly, histone family was upregulated in the cDNA microarray assay. The genes related to calcium channel and caspase were significantly increased (fold ratio > 2.0). However, the genes related to cell cycle, cellular proliferation, and gene transcription were generally decreased their expression (fold ratio<-2.0). We tested the effect of 4HR on cancer cell proliferation. As shown in Fig. 2, 4HR significantly inhibited cell proliferation with the profound effect from 5 μg/ml (p < 0.05).
Table 1
The results of two-dimensional electrophoresis and Q-tof
Spot N.
Control intensity
4HB intensity
Gene name
Protein name
1
64,786
0
HNRPK
Heterogeneous nuclear ribonucleoprotein K isoform a
2
44,441
10
HNRPK
Heterogeneous nuclear ribonucleoprotein K isoform a
3
64,032
10
KRT9
Keratin 9
4
49,739
10
HNRPC
Heterogeneous nuclear ribonucleoprotein C isoform b
5
94,978
10
HNRPC
HNRPC protein
6
274,978
10
HNRPC
HNRPC protein
7
34,603
10
KRT9
Cytokeratin 9
8
42,731
10
KRT1
Keratin 1
9
53,724
10
TPI1
Triosephosphate isomerase 1
10
63,649
13,094
PTMS
Parathymosin
11
65,855
10
PRDX2
Peroxiredoxin 2 isoform b
12
93,949
10
Ubc
Ubc protein
13
39,829
7239
S100
Homo sapiens S100 calcium-binding protein A11
14
63,786
304,971
KRT1
Keratin 1
15
2031
116,114
KRT1
Keratin, type II cytoskeletal 1
16
11,423
92,533
NPM1
B23 nucleophosmin
17
10,371
132,731
NPM1
B24 nucleophosmin
18
9385
115,967
NPM1
Nucleophosmin 1
19
3503
584,841
H2BFN
Histone H2B (H2B)
20
100
42,623
KRT10
Keratin 10
Table 2
The results of cDNA microarray. The genes of interest were shown among the genes which showed significant changes at 12 h after 4HR application (10 μg/mL)
Title
GenBank
Fold-ratio
Apoptosis-associated tyrosine kinase
AK131529
3.395
Block of proliferation 1
NM_015201
2.254
Calcium channel, voltage-dependent, T type, alpha 1G subunit
NM_018896
4.046
Caspase 2
NM_032982
2.697
Caspase 6
NM_001226
2.188
Caspase 8
NM_033356
2.049
Collagen type I, alpha 2
NM_000089
2.168
Collagen type IV, alpha 1
NM_001845
2.334
Collagen type V, alpha 2
NM_000393
2.396
H2A histone family, member V
NM_012412
2.117
H2A histone family, member Y
NM_138610
2.021
H3 histone, family 3B (H3.3B)
NM_005324
2.261
Interleukin 1, beta
NM_000576
2.568
Involucrin
NM_005547
3.176
Keratin 13
NM_002274
2.718
Keratin 14
NM_000526
2.823
Cyclin C
NM_005190
− 3.460
Mitogen-activated protein kinase 1
NM_002745
− 3.663
Mitogen-activated protein kinase 13
NM_002754
− 2.024
Mitogen-activated protein kinase 6
NM_002748
− 3.003
Mitogen-activated protein kinase kinase 4
NM_003010
− 3.497
Polymerase (RNA) I polypeptide B, 128 kDa
NM_019014
− 2.079
Polymerase (RNA) II (DNA directed) polypeptide B, 140 kDa
NM_000938
− 2.421
Polymerase (RNA) II (DNA directed) polypeptide K, 7.0 kDa
NM_005034
− 3.165
Polymerase (RNA) III (DNA directed) polypeptide B
NM_018082
− 2.041
Serine threonine kinase 39
NM_013233
− 2.075
Serine threonine kinase 17a
NM_004760
− 2.016
Serine threonine kinase 38
NM_007271
− 3.413
Transforming growth factor, alpha
NM_003236
− 2.513

Discussion

In this study, 4HR accelerated carcinoma epithelial cell differentiation showing upregulation of involucrin and keratins expression (Fig. 1 and Table 2). 4HR increased the expression of histone family in both proteomic analysis (Fig. 1) and cDNA microarray assay (Table 2). Although this study focused on SCC-9 cells and OSCC, we also observed the inhibitory action of 4HR on breast carcinoma cell lines [18]. Besides, 4HR inhibited cell proliferation-related genes including cyclin C and other RNA polymerases by cDNA microarray assay (Table 2). Cyclins may be an important target for 4HR mediated antiproliferative actions. Supportively, 4HR also inhibits cell proliferation of ras oncogene transformed fibroblasts not in normal fibroblasts [19].
4HR also increases epithelial cell differentiation in SCC-9 cells showing the upregulation of various keratins and involucrin, which is observed both in vitro SCC-9 cell culture system and in vivo SCC-9 cell implanted xenograft model [12]. We further confirmed the upregulation of keratins and involucrin by cDNA microarray and proteomic analysis (Fig. 1 and Table 2). Interestingly, 4HR increased several voltage-dependent calcium channels (Table 2). Indeed, 4HR stimulates intracellular calcium uptake [13]. 4HR mediated increase of calcium uptake is due partly to the upregulation of calcium channels (Table 2). Finding the evidence of tumor cell differentiation is very important because it will minimize host damage induced by conventional therapy. Therefore, the study on the chemically induced tumor differentiation should be encouraged. However, it is far behind to explain the mechanism of 4HR mediated acceleration of SCC-9 cell differentiation.
Mechanistically, 4HR mediated various effects on cancer cells may be due in part to the different expression of unidentified 4HR receptors in tumor cells compared to control cells. We do not know the 4HR receptor and its signal transduction pathways except the increase of calcium level at this moment [13]. The increase of calcium uptake by 4HR is the only known phenomenon at this moment with regard to the signaling pathway [13]. Intracellular calcium is broadly related to cell proliferation, differentiation, and apoptosis. Blocking of calcium channels attenuated 4HR mediated antiproliferative and apoptotic effects on cancer cell lines [13]. Interestingly, the elevated calcium level by 4HR seems similar to the increase of intracellular content of calcium in bacterial cells by 4HR [20]. An increase of calcium uptake by 4HR may be an essential step for various biological effects on cells. Importantly, an increase in the intracellular calcium may result in changes of the expression of differentiation markers [21]. According to the known concepts, tumorigenesis is a cellular dedifferentiation and the intracellular signal pathway is directed to the uncontrolled growth [22]. Tumor growth and development are coupled with down-regulation of differentiation-related calcium binding or modulating genes [23], so it can be assumed a positive relationship between tumorigenesis and down-regulation of these genes. Regarding that, the cellular differentiation is largely dependent on calcium [24] and the observed effects of 4HR is due to the increase of its intracellular level in SCC-9 cells. Revertant function of 4HR may be dependent on the increase of calcium uptake because an increased calcium uptake stimulates the cellular differentiation in the normal keratinocytes [24, 25]. Other signal molecules or downstream target molecules may play an important role for 4HR-mediated cellular effects. Protein kinase C-α, for example, plays an important role in calcium-induced keratinocytes differentiation [26]. It is definitely necessary to pursue the precise molecular mechanism of 4HR mediated antitumor effects.
Noteworthy, the action of 4HR is dose-dependent: being introduced at relatively high doses (5-10 μg/mL), 4HR caused the rupture of cellular membranes in cells and possessed cytotoxic action [12]. This is similar to the effect of conventional anti-cancer drugs that are usually toxic and induce apoptosis in cancer cells where DNA looks as fragmented material and protein synthesis is inhibited [27]. However, the antiproliferative effect of 4HR at low concentration (1 μg/mL) is not followed by appearance of cytotoxicity or apoptosis signs [12]. In similar concentrations (0.1-1 mM), 4HR and resveratrol are not cytotoxic to human lymphocytes [28]. As for the potential use of 4HR as an anti-cancer drug, we have to mention the previous toxicology and carcinogenesis studies demonstrating that the oral administration of 4HR in doses up to 650–1000 mg/kg to animals unaffected their survival [9]. In the Zebra fish study, the administration of 4HR in doses up to 1 mM (194 μg/ml) is not teratogenic to the developing embryo [18]. The effective dose of 4HR, used for injections of carcinoma-grafted nude mice, was 10 mg/kg body weight, i.e., two orders of magnitude less, and caused no toxic side effects in our in vivo experiments [12]. They showed the similar action of 4HR on SCC-9 cells xenografted nude mice model, that is, the significant deceleration of tumor growth and the elicitation promotion of cellular differentiation followed by the formation of keratinous matrix in which individual cells underwent contact inhibition [12].
The clinical use of 4HR or cognate substances should require a careful selection of active doses. This is important not only to controlling the type of biological effect but also to avoid a side effect since a prolonged use of 4HR may cause nephropathy and osteosclerosis [29], which can be explained based on 4HR-induced increase of intracellular calcium [13]. Historically, 4HR was used for the therapeutic drug for infectious disease and its solution in olive oil had been taken by human without any complication [27, 28]. Now, it is a component of topical antiseptics on oral mucosa (C0691518: information was derived from the NIH UMLS). In some bacterial species, extracellular alkylresorcinols play as regulatory factors, are accumulated in developing microbial cultures and, when reaching a threshold level, entering them to the stationary phase. Further increase in alkylresorcinol concentration elicits entering of bacteria to a dormant state followed by the formation of morphologically distinct cyst-like cells [30]. Similar analogy, opportunistic pathogens, such as Pseudomonas aeruginosa, produce N-(3-oxo-dodecanoyl) homoserine lactone which selectively impairs the regulation of NF-kB functions in activated mammalian cells [31].

Conclusion

In this study, the administration of 4HR on SCC-9 cells increased epithelial cell differentiation markers such as involucrin and keratins. The expression of histone was also increased by 4HR administration.

Acknowledgements

Authors appreciated to Dr. Chang-Hoon Chae for his help on this experiment.

Declarations

Not applicable.
Not applicable.

Competing interests

Authors declare that they have no competing interests. KSG is an editorial board member of “Maxillofacial Plastic and Reconstructive Surgery.”
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
7.
Zurück zum Zitat Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63(8):1727–1730PubMed Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63(8):1727–1730PubMed
9.
Zurück zum Zitat Program NT (1988) NTP toxicology and carcinogenesis studies of 4-hexylresorcinol (CAS No. 136-77-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 330:1–166 Program NT (1988) NTP toxicology and carcinogenesis studies of 4-hexylresorcinol (CAS No. 136-77-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 330:1–166
11.
Zurück zum Zitat Kim SG, Lee SW, Park YW, Jeong JH, Choi JY (2011) 4-Hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells. Oncol Rep 26(6):1527–1532PubMed Kim SG, Lee SW, Park YW, Jeong JH, Choi JY (2011) 4-Hexylresorcinol inhibits NF-κB phosphorylation and has a synergistic effect with cisplatin in KB cells. Oncol Rep 26(6):1527–1532PubMed
19.
30.
Zurück zum Zitat El'-Registan GI, Tsyshnatii GV, Duzha MV, Pronin SV, Mitiushina LL (1980) Regulation of Pseudomonas carboxydoflava growth and development by specific endogenous factors. Mikrobiologiia 49(4):561–565PubMed El'-Registan GI, Tsyshnatii GV, Duzha MV, Pronin SV, Mitiushina LL (1980) Regulation of Pseudomonas carboxydoflava growth and development by specific endogenous factors. Mikrobiologiia 49(4):561–565PubMed
Metadaten
Titel
The effect of 4-hexylresocinol administration on SCC-9 cells: mass spectrometric identification of proteins and cDNA microarray analysis
verfasst von
Yei-Jin Kang
Seong-Gon Kim
Publikationsdatum
01.12.2021
Verlag
Springer Singapore
Erschienen in
Maxillofacial Plastic and Reconstructive Surgery / Ausgabe 1/2021
Elektronische ISSN: 2288-8586
DOI
https://doi.org/10.1186/s40902-021-00314-6

Weitere Artikel der Ausgabe 1/2021

Maxillofacial Plastic and Reconstructive Surgery 1/2021 Zur Ausgabe

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.